CoChat

Treatment-Resistant Panic Disorder

Bandelow, Borwin, Rüther, Eckart · 2004 · CNS Spectrums

The DOI matches its Crossref record; 169 of the 174 references it cites were found in a registry or an index.

Abstract

A substantial number of patients with panic disorder and agoraphobia may remain symptomatic after standard treatment (including selective serotonin reuptake inhibitors, tricyclic antidepressants, benzodiazepines, or irreversible monamine oxidase inhibitors). In this review, recommendations for the treatment of patients with panic disorder and agoraphobia who do not respond to these drugs are provided. Nonresponse to drug treatment could be defined as a failure to achieve a 50% reduction on a standard rating scale after a minimum of 6 weeks of treatment in adequate dose. When initial treatments have failed, the medication should be changed to other standard treatments. In further attempts at treatment, drugs should be used that have shown promising results in preliminary studies, such as venlafaxine. Combination treatments may be used, such as the combination of an selective serotonin reuptake inhibitor and a benzodiazepine. Psychological treatments such as cognitive-behavioral therapy have to be considered in all patients, regardless whether they are nonresponders or not. According to existing studies, a combination of pharmacologic treatment with cognitive-behavioral therapy can be recommended.

Overview

Integrity signals

Registry

Crossref · 10.1017/s1092852900022379

Cites

169 of 169 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 169 references

Research works printed but not linked: 14

  1. Mavissakalian, 1983, Agoraphobia: behavioral and pharmacological treatment (n=49), Psychopharmacol Bull, 19, 116
  2. 1991, International Classification of Diseases
  3. Barlow, 1994, Treatment of panic disor-der. A consensus development conference, 105
  4. 10.1002/(sici)1099-1077(199908)14:6<435::aid-hup109>3.0.co;2-b · doi:10.1002/(sici)1099-1077(199908)14:6<435::aid-hup109>3.0.co;2-b
  5. 10.1016/s0005-7894(05)80266-7 · DOI · Paper page
  6. 10.3109/10401239909147053 · doi:10.3109/10401239909147053
  7. 10.1037/0022-006x.68.6.947 · doi:10.1037/0022-006x.68.6.947 · Paper page
  8. 10.1037/0022-006x.68.1.13 · DOI · Paper page
  9. 10.1034/j.1600-0447.2001.00263.x · DOI · Paper page
  10. 10.1037/0022-006x.62.4.865 · DOI · Paper page
  11. 10.1001/archpsyc.1983.01790020047004 · DOI · Paper page
  12. 10.1037/0022-006x.65.6.1026 · doi:10.1037/0022-006x.65.6.1026
  13. 1994, Diagnostic and Statistical Manual of Mental Disorders
  14. 10.1037/0022-006x.63.5.823 · doi:10.1037/0022-006x.63.5.823 · Paper page

Cited by

See all 57

Metadata

Authors
Bandelow, B., & Rüther, E.
Affiliations
University of Göttingen (DE)
Venue
CNS Spectrums
Published
2004-10
Volume
9
Issue
10
Pages
725-739
ISSN
  • 1092-8529 (ISSN-L)
  • 2165-6509
OpenAlex
W2242812184
Cited by
57
References
174
Citations by year
2026: 2 · 2025: 2 · 2024: 3 · 2023: 3 · 2021: 3 · 2017: 2 · 2015: 5 · 2014: 1 · 2013: 2 · 2012: 9
FWCI
0.67
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Spectrums (publishedVersion)
  • PubMed (publishedVersion)
  • GRO (submittedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
  • Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
Keywords
panic disorder, agoraphobia, treatment-resistant depression, venlafaxine, selective serotonin reuptake inhibitors, benzodiazepines, tricyclic antidepressants, combination pharmacotherapy, cognitive behavioral therapy, psychological intervention
MeSH terms
Antidepressive Agents, Tricyclic, Benzodiazepines, Brain, Combined Modality Therapy, Drug Administration Schedule, Drug Resistance, Humans, Monoamine Oxidase Inhibitors, Exercise, Cognitive Behavioral Therapy, Panic Disorder

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment-Resistant Panic Disorder. https://app.cochat.ai/papers/10.1017/s1092852900022379
The paper
Bandelow, B., & Rüther, E. (2004). Treatment-Resistant Panic Disorder. CNS Spectrums. https://doi.org/10.1017/s1092852900022379

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.